Last edition
News about
DCGI Issues Alert Against Antacid Digene Gel, Abbott Initiates Voluntary Recall
The company announced that it had withdrawn all its batches that were being manufactured at its Goa facility following a complaint from a customer that the liquid in the bottle had turned white, tasted bitter, and had a pungent smell when they bought it
Swissport Expands Pharma Network to Toronto
Swissport's cargo facilities at Liège Airport (LGG) in Belgium and Toronto Pearson International Airport (YYZ) in Canada have received IATA's CEIV Pharma certification, the company's 16th and 17th pharma warehousing certifications, respectively.
SOMAI Pharmaceuticals Receives EU-GMP Certification at Lisbon Facility
SOMAÍ also announced that it had raised €5 million to fund its activities.
Element Unveils Fully Integrated Pharma Services Platform
The strategic initiative brings together the capabilities of its recent North American acquisitions of Nanosyn and JMI labs into its existing life sciences business.
Enzene Biosciences Inaugrates R&D Centre with Open Lab Setup in Pune
Enzene Biosciences Ltd. announced the inauguration of its research and development (R&D) facility in Pune.
Cipla Medpro South Africa Pty Ltd to Acquire Actor Pharma
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities and leverage cost synergies in the South African market.
Caplin Steriles Gets Establishment Inspection Report from US FDA
The unit underwent an inspection from US FDA and the inspection classification was determined by the agency as Voluntary Action Indicated (VAI).
UK MHRA Renews GMP Compliance of Kopran's Two Plants
This development illustrates the company's commitment to work closely with the MHRA-UK and strive for 100 Percent cGMP Compliance at its manufacturing facilities.
Nottingham Researchers Gets Major Funds for Sustainable Pharma Manufacturing
Researchers from the University of Nottingham have joined forces with biotechnology company HydRegen for a project that will unlock sustainable biocatalytic hydrogenation – allowing the process to be scaled up and improved for industry use.
Shilpa Pharma Lifesciences Ltd, Unit II Cleares GMP inspection by PMDA in Karnataka
The facility is involved in manufacturing various oncology and non?oncology APIs.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy